Internal Medicine, Endocrinology, Diabetes, & Metabolism · Buffalo, NY
NPI
1144217621
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3 Gates Cir, Diabetes Center of Wny
Buffalo, NY, 14209
Phone (716) 887-4069
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
391 services
Medicare patients, 2024
145
Average age 67
Drug cost, 2024
$2.1M
5,856 prescriptions
Company payments, 2023
$2,000
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paresh Dandona was code 99214 (office e&m - established), 243 times for 122 patients. In total Paresh Dandona billed 391 services in 10 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 243 | 122 | $86.23 | $21K |
| 99204 Office E&M - New | Office | 29 | 29 | $118.29 | $3,430 |
| 82947 Clinical Chemistry | Office | 22 | 15 | $3.85 | $84.7 |
By year: 2022 $32K for 519 services; 2023 $29K for 475 services; 2024 $28K for 391 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 22 | 15 | $3.85 | $84.7 |
Medicare prescription drug claims, 2024
In 2024, the drug Paresh Dandona prescribed most often to Medicare patients was Pioglitazone Hcl, with 846 prescriptions and refills. In total Paresh Dandona wrote 5,856 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pioglitazone Hcl Generic | 846 | 1,959 | 221 | $12K |
| Ozempic Semaglutide | 656 | 1,047 | 147 | $969K |
| Levothyroxine Sodium Generic | 423 | 1,051 | 112 | $7,174 |
| Glimepiride Generic | 387 | 796 | 92 | $4,971 |
| Metformin Hcl Generic | 334 | 808 | 94 | $4,541 |
| Mounjaro Tirzepatide | 254 | 290 | 55 | $291K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 219 | 471 | 63 | $33K |
| Rosuvastatin Calcium Generic | 215 | 561 | 65 | $3,185 |
| Jardiance Empagliflozin | 178 | 301 | 31 | $173K |
| Atorvastatin Calcium Generic | 168 | 374 | 40 | $2,189 |
| Metformin Hcl Er Metformin Hcl | 118 | 307 | 37 | $2,599 |
| Estradiol Generic | 117 | 268 | 36 | $2,334 |
| Trulicity Dulaglutide | 106 | 199 | 28 | $188K |
| Spironolactone Generic | 82 | 192 | 23 | $1,208 |
| Acarbose Generic | 81 | 177 | 23 | $3,069 |
Brand drugs: 2,024 claims; generic drugs: 3,640 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Paresh Dandona $2,000 ($2,000 in general payments such as food, travel and fees) from 1 company. The largest payer was Marius Pharmaceuticals, Inc with $2,000.
| Company | Payments | Amount |
|---|---|---|
| Marius Pharmaceuticals, Inc | 1 | $2,000 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.